TE
AKRO

Tema ETFs’s Akero Therapeutics AKRO Stock Holding History

Tema ETFs’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,632
Closed -$315K – 561
2025
Q3 		$315K Sell
6,632
-3,607
-35% -$175K 0.03% 454
2025
Q2 		$546K Sell
10,239
-1,539
-13% -$69.9K 0.15% 132
2025
Q1 		$477K Sell
11,778
-20,372
-63% -$863K 0.14% 113
2024
Q4 		$894K Buy
+32,150
New +$974K 0.37% 69

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tema ETFs's AKRO Position: Q4 2025 in Review

Tema ETFs sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 6,632 shares — an estimated $315K sold.

Tema ETFs first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $894K in Q4 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Tema ETFs reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tema ETFs sold 6,632 Akero Therapeutics shares in Q4 2025, an estimated $315K.
  • Tema ETFs first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
  • Tema ETFs's Akero Therapeutics position peaked at $894K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Tema ETFs's 13F filing for Q4 2025, filed 16 Jan 2026.